Yi Lin

3:38
Anti-BCMA CAR T-cells in myeloma: what data do we have so far?
Yi Lin
3:17
Anti-BCMA CAR T-cells for MM: durable clinical responses with bb2121
Yi Lin
1:46
Next-generation CAR T-cell products for 2018
Yi Lin
2:38
Prophylactic treatment for CAR T-cell toxicity shows promising results
Yi Lin
2:00
ZUMA-1 trial: FDA approval and follow-up of CAR T-cell product axicabtagene ciloleucel
Yi Lin
9:48
The use of CAR T-cells in multiple myeloma
Adam Cohen et al.
2:24
ZUMA-1: a pivotal trial of axicabtagene ciloleucel (AXI-CEL; KTE-C19) in patients with NHL
Yi Lin
3:58
ZUMA-1: a pivotal trial of CAR T-cells in NHL
Yi Lin
3:14
bb2121: bringing CAR T-cells into the multiple myeloma world
Yi Lin
The content of VJHemOnc is intended for healthcare professionals